Literature DB >> 3062297

Magnetic resonance imaging of the menstrual cycle.

C L Janus1, H P Wiczyk, N Laufer.   

Abstract

This study examines the ability of magnetic resonance imaging (MRI) to monitor follicular and endometrial development during the menstrual cycle. MR scans, sonograms and hormonal levels of estradiol (E2) and progesterone (P) obtained from five ovulatory volunteers were evaluated on approximately days 4, 8, 12, 16, 20 and 24 of the cycle. MRI reliably demonstrated folliculogenesis in all of the volunteers. Changes depicted in the endometrial and junctional zones of the uterus reflected physiologic events occurring during the normal cycle. Important implications exist for infertile women undergoing stimulated cycles and/or in-vitro fertilization.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3062297     DOI: 10.1016/0730-725x(88)90091-4

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  4 in total

Review 1.  Nuclear magnetic resonance in clinical pharmacology and measurement of therapeutic response.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

2.  Magnetic resonance imaging of bovine ovaries in vitro.

Authors:  G E Sarty; E J Kendall; R A Pierson
Journal:  MAGMA       Date:  1996 Sep-Dec       Impact factor: 2.310

3.  3-T diffusion tensor imaging (DTI) of normal uterus in young and middle-aged females during the menstrual cycle: evaluation of the cyclic changes of fractional anisotropy (FA) and apparent diffusion coefficient (ADC) values.

Authors:  Y He; N Ding; Y Li; Z Li; Y Xiang; Z Jin; H Xue
Journal:  Br J Radiol       Date:  2015-03-18       Impact factor: 3.039

4.  Brain structural and functional changes during menstrual migraine: Relationships with pain.

Authors:  Zi-Wen Wang; Zi-Han Yin; Xiao Wang; Yu-Tong Zhang; Tao Xu; Jia-Rong Du; Yi Wen; Hua-Qiang Liao; Yu Zhao; Fan-Rong Liang; Ling Zhao
Journal:  Front Mol Neurosci       Date:  2022-09-14       Impact factor: 6.261

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.